Homogeneous immunoassay of whole-blood samples

Area of Science:

• Biochemistry
• Immunology
• Medical Diagnostics

Background:

• Point-of-care testing requires rapid and quantitative assays.
• Existing immunoassays often require complex sample preparation or laboratory equipment.
• Integrating immunological and biochemical reactions can enhance assay performance.

Purpose of the Study:

• To establish proof of principle for a novel, rapid, quantitative, homogeneous immunoassay.
• To develop a point-of-care assay for whole-blood analysis.
• To utilize patented technologies for enhanced immunoassay capabilities.

Main Methods:

• Developed a homogeneous immunoassay combining an immunological front end with a coagulation cascade chemistry back end.
• Employed two patented technologies: a serine protease inhibitor and paramagnetic iron oxide particles (PIOP).
• Created a model steric-hindrance immunoassay for biotin measurement using inhibited biotinylated thrombin, anti-biotin monoclonal antibody, and PIOP on test cards.

Main Results:

• Demonstrated proof of principle for the rapid, quantitative, homogeneous immunoassay.
• Successfully analyzed whole-blood samples using test cards and a small point-of-care instrument.
• Established a calibration curve for biotin measurement in plasma samples.

Conclusions:

• The novel immunoassay is capable of rapid, quantitative analysis of whole-blood samples at the point of care.
• The combination of patented technologies enables a unique approach to immunoassay design.
• This method holds promise for improved diagnostic capabilities in various settings.